SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001387131-20-005869
Filing Date
2020-06-22
Accepted
2020-06-22 17:13:45
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDED SC13D tbph-sc13da_062220.htm SC 13D/A 69570
2 INDENTURE ex-8.htm EX-8 709867
3 REGISTRATION RIGHTS AGREEMENT ex-9.htm EX-9 87108
4 WAIVER AND ASSIGNMENT OF REGISTRATION RIGHTS AND VOTING AGREEMENT ex-10.htm EX-10 50121
5 COOPERATION AGREEMENT ex-11.htm EX-11 29227
6 GRAPHIC ex8001.jpg GRAPHIC 75899
  Complete submission text file 0001387131-20-005869.txt   1052114
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88552 | Film No.: 20979557
SIC: 2834 Pharmaceutical Preparations